|
US4115577A
(en)
*
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4183936A
(en)
*
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4013652A
(en)
*
|
1972-06-19 |
1977-03-22 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzoxazine
|
|
CH644602A5
(de)
*
|
1978-06-05 |
1984-08-15 |
Sankyo Co |
Benzothiazocin- und benzothiazoninderivate, ihre herstellung und diese derivate enthaltende pharmazeutische praeparate.
|
|
US4219550A
(en)
*
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
|
US4997831A
(en)
*
|
1988-09-01 |
1991-03-05 |
Glaxo Group Limited |
Lactam derivatives
|
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
|
EP0380155A1
(fr)
*
|
1989-01-19 |
1990-08-01 |
Duphar International Research B.V |
Dérivés de 1,2,3,4-tétrahydro-bêta-carboline, 8,9-annelés
|
|
US6713471B1
(en)
*
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
US7071186B2
(en)
*
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
AR024378A1
(es)
|
1999-06-15 |
2002-10-02 |
Du Pont Pharm Co |
Gamma-carbolinas fusionadas heterociclicas sustituidas
|
|
ES2329553T4
(es)
|
2000-12-20 |
2010-12-07 |
Bristol-Myers Squibb Company |
Pirroloquinolinas y piridoquinolinas sustituidas como agonistas y antagonistas de serotonina.
|
|
KR20030070073A
(ko)
*
|
2000-12-20 |
2003-08-27 |
브리스톨-마이어스스퀴브컴파니 |
세로토닌 효능제 및 길항제로서의 치환된 피리도인돌
|
|
BR0116347A
(pt)
|
2000-12-20 |
2004-07-06 |
Bristol Myers Squibb Pharma Co |
Derivados pirazinoquinoxalina substituìdos como agonistas e antagonistas do receptor de serotonina
|
|
US6849619B2
(en)
*
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
AU2002336749A1
(en)
|
2001-09-21 |
2003-04-01 |
Pharmacia And Upjohn Company |
Tricyclic indole derivatives as 5-ht ligands
|
|
ES2364046T3
(es)
*
|
2002-12-19 |
2011-08-23 |
Bristol-Myers Squibb Company |
Gamma-carbolinas tricíclicas sustituidas utilizadas como agonistas y antagonistas de los receptores de la serotonina.
|
|
CA2679754C
(fr)
|
2007-03-12 |
2018-08-07 |
Intra-Cellular Therapies, Inc. |
Synthese de gamma-carbolines fusionnees a heterocycles substitues
|
|
WO2011044134A1
(fr)
|
2009-10-05 |
2011-04-14 |
Albany Molecular Research, Inc. |
Dérivés d'épiminocycloalkyl(b)indole utilisés en tant que modulateurs du récepteur de la sérotonine de sous-type 6 (5-ht6) et leurs utilisations
|
|
AU2012207335A1
(en)
|
2011-01-19 |
2013-07-25 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
|
|
JP2015514135A
(ja)
|
2012-04-14 |
2015-05-18 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規組成物および方法
|
|
DK2968320T3
(da)
|
2013-03-15 |
2021-02-01 |
Intra Cellular Therapies Inc |
Organiske forbindelser
|
|
CA3148303C
(fr)
|
2013-12-03 |
2024-02-27 |
Intra-Cellular Therapies, Inc. |
Composes de gamma-carboline fusionnes heterocycliques pour l'utilisation dans le traitement des troubles bipolaires
|
|
CA2944755A1
(fr)
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Composes organiques
|
|
CA2944512C
(fr)
|
2014-04-04 |
2018-04-24 |
Intra-Cellular Therapies, Inc. |
Carbolines gamma fusionnees heterocycliques destinees au traitement de troubles du systeme nerveux central
|
|
PT3407888T
(pt)
|
2016-01-26 |
2021-03-19 |
Intra Cellular Therapies Inc |
Compostos de piridopirroloquinoxalina, suas composições e utilizações
|
|
SI3407889T1
(sl)
|
2016-03-25 |
2021-09-30 |
Intra-Cellular Therapies, Inc. |
Organske spojine in njihova uporaba v zdravljenju ali preprečevanju motenj centralnega živčnega sistema
|
|
EP3436455A4
(fr)
|
2016-03-28 |
2019-09-04 |
Intra-Cellular Therapies, Inc. |
Nouveaux sels et cristaux
|
|
EP3436016B1
(fr)
|
2016-03-28 |
2022-04-27 |
Intra-Cellular Therapies, Inc. |
Nouveaux co-cristaux
|
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
JP7013454B2
(ja)
|
2016-10-12 |
2022-02-15 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
アモルファス固体分散体
|
|
WO2018126143A1
(fr)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Composés organiques
|
|
WO2018126140A1
(fr)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Composés organiques
|
|
IL304026B2
(en)
|
2017-03-24 |
2024-11-01 |
Intra Cellular Therapies Inc |
A pharmaceutical preparation containing 1-(4-fluoro-phenyl)-4-((Sa10,Rb6)-3-D2-2,2-methyl-2, 3, a10, 10, 9, b6- hexahydro-H7, H1- Pyrido[3',4',:4,5]pyrrolo[3,2,1-de]quioxalin-8-yl)-butan-1-one and its uses
|
|
US11427587B2
(en)
|
2017-07-26 |
2022-08-30 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
JP7223742B2
(ja)
|
2017-07-26 |
2023-02-16 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
IL277504B1
(en)
|
2018-03-23 |
2026-02-01 |
Intra Cellular Therapies Inc |
Deuterium-converted ((sa10,rb6)-8-(3-(4-fluorophenoxy)propyl 6b, 7, 8, 9, 10, 10a-hexahydro-1h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-82(h3)-one compounds, pharmaceutical composition containing them and their uses
|
|
JP7476115B2
(ja)
|
2018-06-06 |
2024-04-30 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
新規の塩および結晶
|
|
WO2019237037A1
(fr)
|
2018-06-08 |
2019-12-12 |
Intra-Cellular Therapies, Inc. |
Nouvelles méthodes
|
|
DK3609891T3
(da)
|
2018-06-11 |
2026-02-23 |
Intra Cellular Therapies Inc |
Syntese af substituerede heterocykliske fusionerede gamma-carboliner
|
|
US12144808B2
(en)
|
2018-08-29 |
2024-11-19 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
AU2019328528B2
(en)
|
2018-08-31 |
2025-01-23 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
MX2021002321A
(es)
|
2018-08-31 |
2021-04-28 |
Intra Cellular Therapies Inc |
Nuevos metodos.
|
|
CN114072150A
(zh)
|
2019-07-07 |
2022-02-18 |
细胞内治疗公司 |
新方法
|
|
US12414948B2
(en)
|
2022-05-18 |
2025-09-16 |
Intra-Cellular Therapies, Inc. |
Methods
|